| Assessments |
-
•
Should cognitive screening (ie, use of Montreal Cognitive Assessment) be performed in studies evaluating physical performance or motor control?
-
•
What are the best clinical and research tools to evaluate cognitive and physical function in individuals with chronic lung disease?
-
•
What factors should be considered when evaluating cognitive function (ie, age, mood, education level, culture, socioeconomic status)?
-
•
What are the most relevant cognitive domains to evaluate in chronic lung disease?
-
•
What methodologic framework should be applied or developed to refine the variability of cognitive function measurements across research studies?
-
•
What mechanistic approaches could be used to evaluate cognition and motor control in chronic lung diseases?
-
•
How can we evaluate the contribution of lung disease severity compared with other comorbidities that predispose individuals to cognitive impairments?
-
•
Should cognitive screening and assessment of required physical function be integrated into evaluation of inhaler technique?
|
| Outcome measures |
-
•
Can dual-task performance be integrated into clinical practice?
-
•
What is the association between dual-task decrements and outcomes such as falls, balance, daily activities, and health care utilization?
|
| Standard interventions/approaches |
-
•
What cognitive domains can be improved with exercise training?
-
•
What are the effective training protocols for specific cognitive domains?
-
•
Can a threshold of cognitive impairment predict pulmonary rehabilitation engagement or completion?
-
•
Can the use of adaptive platform trials be helpful in comparing various cognitive and exercise training interventions?
-
•
What is the optimal comparator group for assessment of cognition or physical function in people with chronic lung diseases?
-
•
What is the most effective way to educate health care providers regarding cognitive screening and, if needed, more extensive evaluation?
|
